Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2017 | 01-2017 | 10-2016 | 07-2016 | 04-2016 | |
| Sales | 3,425 | 3,791 | 0 | 0 | 0 |
| Gross Profit | 3,425 | 3,791 | N/A | N/A | N/A |
| Operating Expenses | 24,085 | 20,976 | 0 | 16,566 | 15,593 |
| Operating Income | -20,660 | -17,186 | N/A | -16,566 | -15,593 |
| Other Income | 192 | 155 | 0 | 80 | 71 |
| Pre-tax Income | -20,468 | -17,031 | 0 | -16,486 | -15,523 |
| Income Tax | N/A | 50 | N/A | N/A | N/A |
| Net Income Continuous | -20,468 | -17,081 | N/A | -16,486 | -15,523 |
| Net Income | $-20,468 | $-17,081 | $N/A | $-16,486 | $-15,523 |
| EPS Basic Total Ops | -611.69 | -515.74 | N/A | -575.71 | -539.73 |
| EPS Basic Continuous Ops | -609.21 | -510.71 | N/A | -575.21 | -545.48 |
| EPS Diluted Total Ops | -611.69 | -515.74 | N/A | -575.71 | -539.73 |
| EPS Diluted Continuous Ops | -609.21 | -510.71 | N/A | -575.21 | -545.48 |
| EBITDA(a) | $-20,347 | $-16,910 | $N/A | $-16,379 | $-15,402 |